NIKKEI 225
38,102.44 -712.12 (-1.83%) HANG SENG
17,936.12 -5.66 (-0.03%) CRUDE OIL
80.45 +2.00 (+2.55%) GOLD FUTURES
2,333.80 -15.30 (-0.65%) DOW
38,774.93 +185.77 (+0.48%) Bitcoin GBP
52,706.18 +322.39 (+0.62%)
CRSP Sep 2024 45.000 call
| Previous close | 14.00 |
| Open | 14.00 |
| Bid | 11.50 |
| Ask | 13.90 |
| Strike | 45.00 |
| Expiry date | 2024-09-20 |
| Day's range | 14.00 - 14.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 19 |
Globe NewswireCRISPR Therapies Market Research 2024: Pipeline Analysis, Therapeutic Assessment, Unmet Needs, Impact of Drugs
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "CRISPR therapies - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "CRISPR Therapies - Pipeline Insight, 2024," report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of admini
ZacksCRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $65.26, representing a +0.66% change from its previous close.
ZacksCRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
